Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation

about

Development and Validation of a Stability-Indicating Capillary Electrophoresis Method for the Determination of Zolpidem Tartrate in Tablet Dosage Form with Positive Confirmation using 2D- and 3D-DAD Fingerprints.

P2860

Q35193814-B04D6B87-498B-45AB-93E4-06311DDE8687

P2860

Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation

Item

http://www.wikidata.org/entity/Q42557229

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Development and validation of ...... ride in its tablet formulation

@en

Development and validation of ...... ride in its tablet formulation

@nl

type

Item

label

Development and validation of ...... ride in its tablet formulation

@en

Development and validation of ...... ride in its tablet formulation

@nl

prefLabel

Development and validation of ...... ride in its tablet formulation

@en

Development and validation of ...... ride in its tablet formulation

@nl

P1476

Development and validation of ...... ride in its tablet formulation

@en

P2093

Bhavesh Dodiya

http://www.w3.org/2001/XMLSchema#string

Govind Kher

http://www.w3.org/2001/XMLSchema#string

Kapil Dubal

http://www.w3.org/2001/XMLSchema#string

P2860

Development of validated stability-indicating assay methods--critical review.

Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.

Acute and long-term antiplatelet therapy.

The ICH guidance in practice: stress degradation studies on ornidazole and development of a validated stability-indicating assay.

ICH guidance in practice: establishment of inherent stability of secnidazole and development of a validated stability-indicating high-performance liquid chromatographic assay method.

Ticlopidine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study.

Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions.

Quantitative nondestructive methods for the determination of ticlopidine in tablets using reflectance near-infrared and Fourier transform Raman spectroscopy.

P304

159-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSPS.2011.03.005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hitendra S Joshi

Vijay R Ram

P577

2011-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255987566

http://www.w3.org/2001/XMLSchema#string

P698

23960754

http://www.w3.org/2001/XMLSchema#string

P932

3745131

http://www.w3.org/2001/XMLSchema#string

Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation

about

P2860

P2860

Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932